Reverse Transcriptase PCR

Human genetic disorders are a group of diseases caused by gene or chromosome abnormalities that have the characteristics of heredity, diversity, complexity, and difficulty in treatment. In order to effectively diagnose and treat human genetic disorders, it is necessary to detect and analyze the expression of genes at the transcriptional level. A technique that can achieve this goal is reverse transcriptase polymerase chain reaction (RT-PCR). RT-PCR is a molecular biology technique that can convert RNA into DNA and exponentially amplify specific DNA fragments, making it possible to detect and analyze trace amounts of RNA. RT-PCR has the advantages of high sensitivity, high efficiency, high accuracy, etc., and can detect different types and sources of RNA. It can also be combined with other techniques for quantitative analysis, multiplex detection, etc. RT-PCR can be used in the diagnosis of human genetic disorders to detect related gene mutations or expression abnormalities, thereby determining the type, severity, and prognosis of the disease; in the gene therapy of human genetic disorders, it can be used to prepare gene therapy vectors or monitor gene therapy effects, thereby achieving a fundamental treatment of human genetic disorders.

Principles of Reverse Transcriptase PCR

The principle of RT-PCR is to use reverse transcriptase to convert RNA into complementary DNA (cDNA), and then use polymerase to amplify cDNA by PCR.

Table 1. Overview of key enzymes and reagents for RT-PCR

Key enzymes and reagents for RT-PCR Function Source Example
Reverse transcriptase An enzyme that can synthesize cDNA from an RNA template Viral or bacterial origin M-MLV RT, AMV RT, Tth RT
Polymerase An enzyme that can link dNTPs into the DNA chain Bacterial or archaeal origin Taq DNA polymerase, Pfu DNA polymerase
Primer A short oligonucleotide that can bind to the target DNA fragment and guide reverse transcription or PCR amplification Synthetic or natural origin Random primers, specific primers, universal primers
dNTPs Nucleotide monomers that provide the material for DNA chain growth Synthetic or natural origin dATP, dCTP, dGTP, dTTP
Buffer solution A solution that provides the optimal pH value and ion concentration for reverse transcription or PCR reaction Synthetic or natural origin Tris-HCl, KCl, MgCl2
Other auxiliary factors Substances that can improve the efficiency and stability of reverse transcription or PCR reactions Synthetic or natural origin RNase inhibitor, DMSO, betaine

Steps for Reverse Transcriptase PCR

  1. Sample preparation: Choose appropriate samples according to the purpose, such as blood, tissue, cells, etc., and store them at low temperature or in frozen conditions to avoid RNA degradation.
  2. RNA extraction: Use a specialized RNA extraction kit or method and follow the instructions or standard operating procedures to purify and concentrate RNA, check the quality and quantity of RNA, and remove possible DNA contamination.
  3. Reverse transcription: Use reverse transcriptase and specific primers or random primers to convert RNA into cDNA, set appropriate reaction conditions and time, and terminate the reaction.
  4. PCR amplification: Use specific primers and Taq polymerase to amplify cDNA by PCR, set appropriate cycle numbers and temperature programs, and generate target fragments.
  5. Electrophoresis analysis: Use agarose gel or polyacrylamide gel to separate PCR products by electrophoresis; use ultraviolet light or fluorescent dye to detect and quantify; and compare the size relationship between target fragments and molecular weight standards.

Characteristics of Reverse Transcriptase PCR

First, RT-PCR can amplify the target fragment from a very small amount of RNA template, and the detection limit can reach the single-molecule level, which is suitable for the detection of low-abundance or rare transcripts. Second, RT-PCR can only amplify and detect the target sequence by designing specific primers and probes, avoiding non-specific amplification and cross-reaction, and improving the accuracy and reliability of the results. Third, RT-PCR can quantitatively analyze the amplified products by using internal or external standards or a real-time fluorescence detection system, reflecting the relative or absolute content of the RNA template, which is suitable for the study of gene expression levels. Forth, RT-PCR can simultaneously amplify and detect multiple target sequences by using fluorescent probes of different colors or primers of different lengths, saving time and reagents and improving efficiency and information volume. Moreover, RT-PCR can shorten the reaction time and steps by using a fast cycler or a one-step reaction system and realize rapid diagnosis and analysis.

Table 2. Comparison of RT-PCR with other PCR methods

Method Template Steps Sensitivity Specificity Quantification Multiplexing Speed
RT-PCR RNA Reverse transcription + amplification High High High High Medium
Conventional PCR DNA Amplification Medium Medium Low Medium High
Chimeric PCR DNA or RNA Amplification High Medium Low Low Medium
Nested PCR DNA Amplification + amplification High High Low Low Low

Application of Reverse Transcriptase PCR in the Diagnosis of Genetic Diseases

RT-PCR can be used to detect mutations or polymorphisms that lead to monogenic diseases, such as Duchenne muscular dystrophy, galactosemia, Lesch–Nyhan syndrome, etc. RT-PCR can quickly and accurately identify the sequence changes of the disease-causing genes and provide the basis for clinical diagnosis and genetic counseling. In addition, RT-PCR can be used to analyze gene expression levels that affect the occurrence of multifactorial genetic diseases, such as type 2 diabetes, hypertension, Alzheimer's disease, etc. RT-PCR can quantitatively measure gene expression in different tissues or cells and provide information for revealing the molecular mechanisms of multifactorial genetic diseases and discovering potential biomarkers. Also, RT-PCR can be used to detect gene rearrangements or deletions that lead to chromosomal abnormalities, such as chronic myelogenous leukemia, Down syndrome, Edwards syndrome, etc. RT-PCR can sensitively detect fusion genes or missing fragments on chromosomes and provide the basis for the diagnosis and prognosis evaluation of chromosomal abnormalities. What's more, RT-PCR can be used to detect mitochondrial DNA mutations or deletions that lead to mitochondrial diseases such as Leber hereditary optic atrophy, MELAS syndrome, Kearns-Sayre syndrome, etc. RT-PCR can quantitatively measure the mitochondrial DNA content and mutation rate in different tissues or cells and provide evidence for the diagnosis and treatment of mitochondrial diseases.

References

  1. Morlan J, et al. Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method. PLoS One. 2009 Feb 25;4(2):e4584.
  2. Shrestha R. Reverse transcriptase (RT)-PCR: Principles, Applications. Microbe Online. 2022 Sep 17; Available from: https://microbeonline.com/rt-pcr-principles-applications/
  3. Bustin SA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009 Apr;55(4):611-22.
  4. Livak KJ, et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8.
  5. Heid CA, et al. Real time quantitative PCR. Genome Res. 1996 Oct;6(10):986-94.
  6. Higuchi R, et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y). 1993 Sep;11(9):1026-30.
  7. Gibson UE, et al. A novel method for real time quantitative RT-PCR. Genome Res. 1996 Oct;6(10):995-1001.
  8. Alwine JC, et al. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5350-4.
  9. Mullis K, et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:263-73.
  10. Spackman E, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002 Sep;40(9):3256-60.
  11. Peiris JS, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24;361(9371):1767-72.
  12. Corman VM, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3).
For research use only. Not intended for any clinical use.